Chief Surgical Officer, Dr. Richard Alexander Recognized for Patient Advocacy 

The Society of Surgical Oncology recognized H. Richard Alexander Jr., MD, FACS, as the recipient of the 2025 Gabriella Graham Patient Advocacy Award for his exceptional work and support of patients and families affected by Pseudomyxoma peritonei (PMP). The award was presented during its recent Advanced Cancer Therapies Meeting. Dr. Alexander has expanded the portfolio of treatment and clinical research options for patients with PMP who may benefit from the surgical treatment of complex, rare, or recurrent cancers.

March is Colorectal Cancer Awareness Month

March is Colorectal Cancer Awareness Month. A great time to remind individuals about the importance of screening and early detection. Colorectal cancer remains the third leading cause of cancer death among both men and women in the nation. If you are 45 years old or older, talk to your doctor about getting screened. Rutgers Cancer Institute and RWJBarnabas Health are a statewide resource in advancing our understanding about colorectal cancer and providing advanced care. 

Recognizing our Dedicated Social Work Team

National Social Work Month in March is a time to celebrate this important profession. This year’s theme is compassion plus action. Through compassion and caring, our social work team provides extensive experience to help patients and their families navigate the cancer journey. From counseling to stress management and support groups, the Social Work Department at Rutgers Cancer Institute serves as a valuable resource for patients. Learn more about services, support and educational programs.



Spotlight on Multiple Myeloma this March

Multiple myeloma is a type of cancer that begins in plasma cells (white blood cells that produce antibodies). Also called Kahler disease, myelomatosis, and plasma cell myeloma. Early signs and symptoms may include bone pain, nausea, constipation, loss of appetite and fatigue. At Rutgers Cancer Institute and RWJBarnabas Health, our multidisciplinary team provides individualized treatment plans tailored for each patient. Led by international experts in the field, our program is at the forefront of multiple myeloma diagnosis and treatment.